drug regulators

Platform trials, which test multiple treatments simultaneously against a shared control group, are increasingly used in medicine and are changing how clinical evidence is generated. Critics and commentators argue that drug regulators have not adapted their evaluation frameworks to this faster, more flexible trial design, raising questions about how such evidence should be assessed and approved.